Global Health Developments: Key Updates on Ebola, Biotech, and Pharma Movements

This health news brief covers various global developments including Apollo Hospitals appointing Shobana Kamineni as executive chair of a Healthtech spin-off. It also highlights the ongoing Ebola crisis in Congo, Adaptive Biotechnologies' business restructuring, Elicio Therapeutics' study setbacks, Sigma Healthcare's market focus, and global pharma investments amidst tariff threats.

In its strategic shift, India's Apollo Hospitals has appointed Shobana Kamineni as executive chairperson of its new entity, Apollo Healthtech. This healthtech spin-off comes as part of Apollo's vision for expansion.

Meanwhile, the Ebola outbreak in eastern Congo continues to pose a grave threat, with the true scale uncertain due to data ambiguities and community resistance, according to responders.

Elsewhere, Adaptive Biotechnologies is separating its immune medicine platform following a business review, while Elicio Therapeutics faces setbacks after its cancer vaccine trial failed. Global drugmakers are also ramping up U.S. investments amid impending tariff threats.